Laboratory Criteria for Exclusion and Readmission of Potentially Infectious Persons in Sensitive Settings in the Age of Culture-Independent Diagnostic Tests: Report of a Multidisciplinary Workgroup.


Journal

Journal of food protection
ISSN: 1944-9097
Titre abrégé: J Food Prot
Pays: United States
ID NLM: 7703944

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 09 06 2023
revised: 23 09 2023
accepted: 27 09 2023
medline: 4 12 2023
pubmed: 6 10 2023
entrez: 5 10 2023
Statut: ppublish

Résumé

Culture-independent diagnostic tests (CIDTs) are increasingly used for clinical diagnosis of gastrointestinal diseases such as salmonellosis, Shiga toxin-producing E. coli disease, and shigellosis because of their speed, convenience, and generally high-performance characteristics. These tests are also used to screen potentially infectious asymptomatic persons during outbreak investigations in sensitive settings such as childcare, food service, and healthcare. However, only limited performance data are available for CIDTs used on specimens from asymptomatic persons. The Association of Public Health Laboratories (APHL) and Council of State and Territorial Epidemiologists (CSTE) convened a workgroup to examine the available scientific data to inform interim decision-making related to exclusion and readmission criteria for potentially infectious persons in sensitive settings, the risks and benefits of different testing strategies, and to identify knowledge gaps for further research. This is the report on the Workgroup findings.

Identifiants

pubmed: 37797737
pii: S0362-028X(23)06857-6
doi: 10.1016/j.jfp.2023.100173
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100173

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

John Besser (J)

Association of Public Health Laboratories, 284 Vickers DR NE, Atlanta, GA 30307, USA. Electronic address: bessej1@gmail.com.

Rachael Singer (R)

Council of State and Territorial Epidemiologists, 2635 Century Parkway NE, Suite 700, Atlanta, GA 30345, USA. Electronic address: rsinger@cste.org.

Rachel H Jervis (RH)

Colorado Department of Public Health and Environment, 4300 Cherry Creek Drive South, Denver, CO 80246, USA. Electronic address: rachel.jervis@state.co.us.

David Boxrud (D)

Centers for Disease Control and Prevention, 1600 Clifton Road NE. Atlanta GA 30329, USA. Electronic address: zaj3@cdc.gov.

Kirk Smith (K)

Minnesota Department of Health, 625 Robert St. N. P.O. Box 64975, St. Paul, MN 55164, USA. Electronic address: kirk.smith@state.mn.us.

Elizabeth R Daly (ER)

Council of State and Territorial Epidemiologists, 2635 Century Parkway NE, Suite 700, Atlanta, GA 30345, USA. Electronic address: edaly@cste.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH